Company Filing History:
Years Active: 2019-2020
Title: Innovations of Luo Heng Qin
Introduction
Luo Heng Qin is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating liver disease. With a total of 3 patents to his name, his work reflects a commitment to advancing medical science.
Latest Patents
Luo Heng Qin's latest patents include innovative compounds known as amino pyrimidine SSAO inhibitors. These inventions provide methods for treating patients suffering from liver disease, showcasing his dedication to improving healthcare outcomes. The compounds are defined by specific formulas, and the patents detail processes for preparing these valuable substances.
Career Highlights
Luo Heng Qin is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its research and development in innovative medicines. His role at the company allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to medical science.
Collaborations
Some of his notable coworkers include David Andrew Coates and Yi Wei. Their collaborative efforts contribute to the innovative environment at Eli Lilly and Company, fostering advancements in pharmaceutical research.
Conclusion
Luo Heng Qin's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and contributions to liver disease treatment highlight the importance of research and collaboration in advancing healthcare solutions.